Makes orthopedic reconstructive products for bone and joint disorders.
Jun 2026Revenue $8.51B/yrExpenses $7.30B/yr
No trend
Figures by year
Is Zimmer Biomet Holdings profitable?
Yes. In the 12 months to Jun 2026, revenue was $8.51B and expenses $7.30B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $8.23B | $7.13B | $1.10B |
| Dec 2024 | $7.68B | $6.39B | $1.29B |
| Dec 2023 | $7.39B | $6.12B | $1.28B |
| Dec 2022 | $6.94B | $6.24B | $696M |
| Dec 2021 | $6.83B | $5.97B | $860M |
| Dec 2020 | $6.13B | $6.04B | $83.1M |
| Dec 2019 | $7.98B | $6.84B | $1.14B |
| Dec 2018 | $7.93B | $7.90B | $33.8M |
| Dec 2017 | $7.80B | $7.00B | $799M |
| Dec 2016 | $7.67B | $6.85B | $821M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.